In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Unitedhealth Group Inc (NYSE: UNH) closed at $501.92 down -0.24% from its previous closing price of $503.12. In other words, the price has decreased by -$0.24 from its previous closing price. On the day, 2.42 million shares were traded. UNH stock price reached its highest trading level at $504.695 during the session, while it also had its lowest trading level at $497.28.
Ratios:
For a deeper understanding of Unitedhealth Group Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.85 whereas as Long-Term Debt/Eq ratio is at 0.74.
On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $597.
HSBC Securities Upgraded its Reduce to Hold on April 04, 2024, while the target price for the stock was maintained at $460.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 08 ’24 when McSweeney Erin sold 1,236 shares for $483.48 per share. The transaction valued at 597,582 led to the insider holds 9,364 shares of the business.
ROOS THOMAS E sold 858 shares of UNH for $451,128 on Feb 23 ’24. The Chief Accounting Officer now owns 32,289 shares after completing the transaction at $525.79 per share. On Feb 16 ’24, another insider, THOMPSON BRIAN R, who serves as the CEO, UnitedHealthcare of the company, sold 28,943 shares for $521.00 each. As a result, the insider received 15,079,303 and left with 25,543 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 461959659520 and an Enterprise Value of 513116667904. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 30.66, and their Forward P/E ratio for the next fiscal year is 16.22. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.37. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.22 while its Price-to-Book (P/B) ratio in mrq is 5.33. Its current Enterprise Value per Revenue stands at 1.352 whereas that against EBITDA is 14.66.
Stock Price History:
Over the past 52 weeks, UNH has reached a high of $554.70, while it has fallen to a 52-week low of $436.38. The 50-Day Moving Average of the stock is 2.45%, while the 200-Day Moving Average is calculated to be -1.43%.
Shares Statistics:
For the past three months, UNH has traded an average of 4.16M shares per day and 3874010 over the past ten days. A total of 924.00M shares are outstanding, with a floating share count of 918.53M. Insiders hold about 0.20% of the company’s shares, while institutions hold 89.65% stake in the company. Shares short for UNH as of 1715731200 were 8114406 with a Short Ratio of 1.95, compared to 1713139200 on 7893592. Therefore, it implies a Short% of Shares Outstanding of 8114406 and a Short% of Float of 0.88.
Dividends & Splits
According to the company, the forward annual dividend rate for UNH is 7.52, from 7.52 in the trailing year. Against a Trailing Annual Dividend Yield of 0.014946733The stock’s 5-year Average Dividend Yield is 1.37.
Earnings Estimates
The performance of Unitedhealth Group Inc (UNH) in the stock market is under the watchful eye of 21.0 analysts actively contributing to its current rating.On average, analysts expect EPS of $6.71 for the current quarter, with a high estimate of $7.17 and a low estimate of $5.86, while EPS last year was $6.14. The consensus estimate for the next quarter is $7.2, with high estimates of $7.43 and low estimates of $6.52.
Analysts are recommending an EPS of between $28.18 and $25.46 for the fiscal current year, implying an average EPS of $27.61. EPS for the following year is $31.03, with 25.0 analysts recommending between $31.85 and $29.74.
Revenue Estimates
For the next quarter, 16 analysts are estimating revenue of $99.08B. There is a high estimate of $100.32B for the next quarter, whereas the lowest estimate is $97.82B.
A total of 21 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $401.74B, while the lowest revenue estimate was $395.49B, resulting in an average revenue estimate of $398.44B. In the same quarter a year ago, actual revenue was $342.52BBased on 21 analysts’ estimates, the company’s revenue will be $428.44B in the next fiscal year. The high estimate is $437.26B and the low estimate is $416.63B.
